MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2026.1842852

Медицинская библиотека · Frontiers in medicine · 2026

Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study.

Gilboa-Sagy Hadas, Romem Ayal, Guber Elad, Epstein Shochet Gali, Eyre Andy, Neuman Yoram, Shitrit David

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Bleeding is the most concerning complication of transbronchial lung cryobiopsy (TBCB). Pulmonary hypertension (PH) is frequently treated as a relative contraindication to bronchoscopic biopsy because of presumed excess bleeding risk, yet TBCB specific data is limited.

METHODS

We conducted a prospective blinded cohort study including consecutive adult patients with interstitial lung disease (ILD) referred to TBCB. All participants underwent pre-procedure transthoracic echocardiography (TTE) with estimation of pulmonary artery systolic pressure (EPASP); bronchoscopists were blinded to TTE results. PH was defined as absent, mild (EPASP 37-50 mmHg) or moderate (51-70 mmHg). Severely elevated EPASP (>70 mmHg) was planned to trigger unblinding but did not occur. Primary outcomes were quantitative bleeding volume, measured by net suction volume, and clinically graded bleeding severity. Secondary outcomes included pneumothorax, hypoxemia, and hypotension.

RESULTS

A total of 74 patients were included; 19 patients met any PH definition (EPASP>36 mmHg). There was an insignificant age difference between any-PH and no-PH groups (66.6 ± 13.4 vs. 59.5 ± 13.2 years, p = 0.052), a slight male preponderance, and increased hypertension and diabetes rates in the any-PH group. There was no association between PH status and bleeding volume (Mann-Whitney-U, p = 0.54), nor across PH severity strata (Kruskal-Wallis, p = 0.52). This was further validated by multivariable log-linear regression. One hypoxemia event occurred; Pneumothorax occurred in 6.8%, with no association with PH (p = 0.51); no hypotension events were observed.

CONCLUSION

TBCB is safe among patients with echocardiographic evidence of mild to moderate PH. These findings should be further studied, yet provide positive prospective evidence.

Для цитирования: Gilboa-Sagy Hadas, Romem Ayal, Guber Elad, Epstein Shochet Gali, Eyre Andy, Neuman Yoram, Shitrit David. Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study.. Frontiers in medicine. 2026. DOI: 10.3389/fmed.2026.1842852.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.